concept

DONANEMAB

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about DONANEMAB: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

82Connections

0Hypotheses

0Analyses

50Outgoing

20Incoming

0Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	DONANEMAB
Key Genes/Proteins	AMYLOID, AMYLOID-BETA, APOE, APP
Related Diseases	ALZHEIMER, ALZHEIMER'S DISEASE, AMYLOID PLAQUES, AUTOPHAGY, COGNITIVE DECLINE

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Donanemab Dosing Regimens Phase 3 for Early Alzheimer's (NCT05738486)

clinical · 1337 words

→

Pathway Diagram

graph TD
    DONANEMAB["DONANEMAB"]
    DONANEMAB -->|"treats"| Cognitive_Decline["Cognitive Decline"]
    DONANEMAB -->|"targets"| Amyloid_Beta["Amyloid Beta"]
    DONANEMAB -->|"targets"| Amyloid__["Amyloid-beta"]
    DONANEMAB -->|"binds_to"| amyloid__["amyloid-beta"]
    DONANEMAB -->|"treats"| Alzheimer_s_disease["Alzheimer's disease"]
    DONANEMAB -->|"targets"| AMYLOID_BETA["AMYLOID-BETA"]
    DONANEMAB -->|"treats"| Early_Stage_Alzheimer_s_Diseas["Early-Stage Alzheimer's Disease"]
    ADUCANUMAB["ADUCANUMAB"] -->|"target for"| DONANEMAB
    AMYLOID["AMYLOID"] -->|"implicated in"| DONANEMAB

Outgoing (62)

Target	Relation	Type	Str
ad_clinical_trial_failures:donanemab	data_in	dataset_row	0.00
ad_clinical_trial_failures:donanemab	data_in	dataset_row	0.00
Amyloid-β	targets	protein	0.95
Amyloid-beta	targets	protein	0.95
amyloid-β	binds_to	protein	0.95
Amyloid β	targets	protein	0.95
Alzheimer Disease	treats	disease	0.95
Amyloid-Β	targets	protein	0.95
Disease Progression	inhibits	process	0.95
Early Symptomatic Alzheimer Disease	treats	phenotype	0.95
Amyloid Clearance	promotes	process	0.95
Amyloid beta	targets	protein	0.95
Cognitive Decline	treats	phenotype	0.95
Alzheimer's disease	treats	disease	0.95
Amyloid clearance	promotes	process	0.92
Aria-E	causes	phenotype	0.92
amyloid-β	targets	compound	0.92
AMYLOID-BETA	targets	protein	0.90
Alzheimer'S Disease	treats	disease	0.90
Early-Stage Alzheimer's Disease	treats	disease	0.90
Amyloid Pathology	targets	mechanism	0.90
Functional Progression	inhibits	phenotype	0.90
ARIA-E	causes	phenotype	0.90
Amyloid-Beta	targets	protein	0.90
ARIA-H	causes	phenotype	0.85
Mild Cognitive Impairment	treats	disease	0.85
Mild Dementia	treats	phenotype	0.85
Alzheimer's Disease	treats	disease	0.85
Aria-H	causes	phenotype	0.82
LECANEMAB	therapeutic_target	drug	0.80
Alzheimer's Disease	treats	disease	0.75
Amyloid Reaccumulation	modulates	process	0.75
AUTOPHAGY	activates	phenotype	0.70
AUTOPHAGY	regulates	phenotype	0.70
TAU	activates	protein	0.65
AMYLOID	targets	protein	0.65
autophagy pathway	modulates	pathway	0.65
AMYLOID	interacts_with	protein	0.65
AMYLOID PLAQUES	protects_against	phenotype	0.65
AMYLOID	causes	protein	0.65
ADUCANUMAB	treats	drug	0.65
ADUCANUMAB	causes	drug	0.65
AMYLOID	activates	protein	0.65
AMYLOID	treats	protein	0.65
APOE4	targets	gene	0.65
AUTOPHAGY	associated_with	phenotype	0.60
STX17	targets	gene	0.55
insulin signaling	modulates	pathway	0.55
epigenetic regulation	modulates	pathway	0.55
HDAC	targets	gene	0.55

Incoming (20)

Source	Relation	Type	Str
ad_clinical_trial_failures:donanemab	data_in	dataset_row	0.00
ad_clinical_trial_failures:donanemab	data_in	dataset_row	0.00
NEUROINFLAMMATION	associated_with	phenotype	0.50
INFLAMMATION	associated_with	phenotype	0.50
ADUCANUMAB	therapeutic_target	drug	0.50
GANTENERUMAB	associated_with	drug	0.45
SOLANEZUMAB	associated_with	drug	0.45
CRENEZUMAB	associated_with	drug	0.45
AMYLOID-BETA	associated_with	protein	0.45
RIVASTIGMINE	associated_with	drug	0.45
DONEPEZIL	associated_with	drug	0.45
ADUCANUMAB	associated_with	drug	0.45
LECANEMAB	associated_with	drug	0.45
COGNITIVE DECLINE	associated_with	phenotype	0.45
AMYLOID PLAQUES	associated_with	phenotype	0.45
AMYLOID	associated_with	protein	0.45
ALZHEIMER	associated_with	disease	0.45
DEMENTIA	associated_with	disease	0.45
ALZHEIMER'S DISEASE	associated_with	disease	0.35
AMYLOID	therapeutic_target	protein	0.35

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning DONANEMAB in their description or question text

No additional research found